- Report
- January 2022
- 60 Pages
Global
From €3797EUR$3,950USD£3,256GBP
- Report
- January 2022
- 200 Pages
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- May 2022
- 39 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Report
- February 2024
- 83 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- May 2021
- 93 Pages
Global
From €3200EUR$3,566USD£2,840GBP
The Circadian Rhythm Sleep Disorder Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat sleep disorders that are caused by disruptions in the body's natural circadian rhythm. These drugs are used to help people fall asleep and stay asleep, as well as to help regulate the body's internal clock. Commonly prescribed drugs in this market include melatonin, ramelteon, and suvorexant.
The Circadian Rhythm Sleep Disorder Drug market is a growing market, as more people are being diagnosed with sleep disorders. This market is expected to continue to grow as more research is conducted into the causes and treatments of sleep disorders.
Some companies in the Circadian Rhythm Sleep Disorder Drug market include Merck, Pfizer, Sanofi, and Takeda. Show Less Read more
